Loading...
At this year's SSC ISTH meeting, held in Milwaukee June 23–26, specialists discussed the latest research in bleeding and clotting. Here, NEJM Journal Watch Oncology and Hematology Associate Editor David Green, MD, PhD, reports on two key presentations. All meeting abstracts can be found at http://onlinelibrary.wiley.com/doi/10.1111/jth.12588/pdf.
Managing bleeding complications from the use of low-molecular-weight heparins and some new, oral anticoagulants is problematic because there are currently no specific inhibitors of these agents. To address this need, investigators from industry and McMaster University in Ontario, Canada, conducted a phase II, randomized, double-blind, placebo-controlled tr…